Tackling the Challenge of Serialisation and Traceability
As counterfeit drug sales become increasingly costly to both pharmaceutical manufacturers and patients, companies are attempting to address the challenges of serialisation and traceability to reduce the burden on health services across the world.
Please note: That all fields marked with an asterisk (*) are required.